RAPT Therapeutics Semi Variance

RAPT Stock  USD 1.12  0.03  2.75%   
RAPT Therapeutics semi-variance technical analysis lookup allows you to check this and other technical indicators for RAPT Therapeutics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
RAPT Therapeutics has current Semi Variance of 23.56. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.

Semi Variance

 = 

SUM(RET DEV)2

N(ZERO)

 = 
23.56
SUM = Summation notation
RET DEV = Actual return deviation over selected period
N(ZERO) = Number of points with returns less than zero

RAPT Therapeutics Semi Variance Peers Comparison

0.0023.560.0052.540.00100%

RAPT Semi Variance Relative To Other Indicators

RAPT Therapeutics is rated second in semi variance category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about  5.05  of Maximum Drawdown per Semi Variance. The ratio of Maximum Drawdown to Semi Variance for RAPT Therapeutics is roughly  5.05 
JavaScript chart by amCharts 3.21.15XLOANTXRAPT 020406080100120140160 01020304050
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare RAPT Therapeutics to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Assets

DSGN
Design Therapeutics
4.68  -0.06  -1.27 
BDTX
Black Diamond Therap
1.94  -0.11  -5.37 
PEPG
PepGen
2.43  0.90  58.82 
PLRX
Pliant Therapeutics
3.26  0.14  4.49 
MOLN
Molecular Partners
4.85  -0.02  -0.41 
ANEB
Anebulo Pharmaceuticals
1.20  -0.03  -2.44 
PMVP
Pmv Pharmaceuticals
1.41  -0.02  -1.4 
HCWB
HCW Biologics
0.38  0.01  2.70 
ANTX
AN2 Therapeutics
1.13  0.02  1.80 
CNTB
Connect Biopharma
0.90  0.05  5.88 
HOWL
Werewolf Therapeutics
1.16  -0.12  -9.38 
GLUE
Monte Rosa Therapeutics
5.45  -0.33  -5.71 
PHVS
Pharvaris BV
15.56  0.10  0.65 
ARVN
Arvinas
17.26  0.12  0.70 
XLO
Xilio Development
0.89  -0.09  -9.18 
RLAY
Relay Therapeutics
3.25  -0.5  -13.33 
STOK
Stoke Therapeutics
7.99  -0.28  -3.39 
TYRA
Tyra Biosciences
11.72  -0.48  -3.93 
MLYS
Mineralys Therapeutics,
9.96  0.28  2.89 
IKNA
Ikena Oncology
1.37  -0.03  -2.14